Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 135 Duryea Rd MELVILLE NY 11747 |
Tel: | 1-631-8435963 |
Website: | https://www.henryschein.com |
IR: | See website |
Key People | ||
Stanley M. Bergman Chairman of the Board, Chief Executive Officer, Director | Christopher Pendergast Senior Vice President, Chief Technology Officer | James P. Breslawski President, Vice Chairman of the Board, Director |
Andrea Albertini President - International Distribution Group | David Brous Chief Executive Officer, Strategic Business Group | Brad Connett Chief Executive Officer, North American Distribution Group |
Rene Willi Chief Executive Officer, Global Oral Reconstruction Group | Michael S. Ettinger Chief Operating Officer, Executive Vice President | Lorelei Mcglynn Senior Vice President, Chief Human Resource Officer | Mark E. Mlotek Chief Strategic Officer, Executive Vice President, Director |
Business Overview |
Henry Schein, Inc. is a solutions company for health care professionals. The Company's business, clinical, technology, and supply chain solutions help office-based dental and medical practitioners work to provide quality care. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites. The Company's Health Care distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products, diagnostic tests, infection-control products, personal protective equipment products (PPE) and vitamins. Its Technology and Value-added services segment provide software, technology and other value-added services to healthcare practitioners. The Company also operates as a supplier of homecare medical products delivered directly to patients in their homes. |
Financial Overview |
For the 39 weeks ended 30 September 2023, Henry Schein, Inc. revenues increased less than 1% to $9.32B. Net income decreased 19% to $398M. Revenues reflect Technology and value-added services segment increase of 11% to $594M, International segment increase of 9% to $2.44B, also reflect Dental segment decrease of 13% to $4.74B, Medical segment decrease of 9% to $2.99B, North America segment decrease of 2% to $6.89B. |
Employees: | 25,000 as of Dec 30, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $11,170M as of Dec 30, 2023 |
Annual revenue (TTM): | $12,339M as of Dec 30, 2023 |
EBITDA (TTM): | $992.00M as of Dec 30, 2023 |
Net annual income (TTM): | $416.00M as of Dec 30, 2023 |
Free cash flow (TTM): | $313.00M as of Dec 30, 2023 |
Net Debt Last Fiscal Year: | $2,180M as of Dec 30, 2023 |
Shares outstanding: | 128,481,162 as of Mar 22, 2024 |
Index Membership: | S&P 500 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |